Global Irbesartan Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Irbesartan is an angiotensin receptor blocker (ARB) indicated to treat hypertension or diabetic nephropathy. It can also be used as part of a combination product with hydrochlorothiazide for patients not well controlled or not expected to be well controlled on monotherapy.
LPI (LP Information)' newest research report, the “Irbesartan Industry Forecast” looks at past sales and reviews total world Irbesartan sales in 2022, providing a comprehensive analysis by region and market sector of projected Irbesartan sales for 2023 through 2029. With Irbesartan sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Irbesartan industry.
This Insight Report provides a comprehensive analysis of the global Irbesartan landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Irbesartan portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Irbesartan market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Irbesartan and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Irbesartan.
The global Irbesartan market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Irbesartan is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Irbesartan is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Irbesartan is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Irbesartan players cover Teva, Sanofi, BMS, Sumitomo Dainippon Pharma, Novartis, Shionogi, Hanall, Taj Pharmaceuticals and Apotex, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Irbesartan market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Irbesartan market?
What factors are driving Irbesartan market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Irbesartan market opportunities vary by end market size?
How does Irbesartan break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Irbesartan is an angiotensin receptor blocker (ARB) indicated to treat hypertension or diabetic nephropathy. It can also be used as part of a combination product with hydrochlorothiazide for patients not well controlled or not expected to be well controlled on monotherapy.
LPI (LP Information)' newest research report, the “Irbesartan Industry Forecast” looks at past sales and reviews total world Irbesartan sales in 2022, providing a comprehensive analysis by region and market sector of projected Irbesartan sales for 2023 through 2029. With Irbesartan sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Irbesartan industry.
This Insight Report provides a comprehensive analysis of the global Irbesartan landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Irbesartan portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Irbesartan market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Irbesartan and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Irbesartan.
The global Irbesartan market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Irbesartan is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Irbesartan is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Irbesartan is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Irbesartan players cover Teva, Sanofi, BMS, Sumitomo Dainippon Pharma, Novartis, Shionogi, Hanall, Taj Pharmaceuticals and Apotex, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Irbesartan market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Combination Drugs
- Prescribed Drugs
- Hyperlipidemia
- High Blood Pressure
- Heart Failure
- Kidney Disease
- Fibrous Fibrillation
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Teva
- Sanofi
- BMS
- Sumitomo Dainippon Pharma
- Novartis
- Shionogi
- Hanall
- Taj Pharmaceuticals
- Apotex
- Jiangsu Hengrui Medicine
- Verdant Life Sciences
- Angita Pharma
- Auro Pharma
- Avanstra
- Zhuhai Rundu Pharma
- Xiansheng Pharmaceutical
- CTTQ
- Tianjin Huairen Pharmaceutical
- Jiangsu Wangao Pharmaceutical
- Zhejiang Huahai Pharmaceutical
- Zhejiang Ainuo Pharmaceutical
- Yuanhe Pharmaceutical
What is the 10-year outlook for the global Irbesartan market?
What factors are driving Irbesartan market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Irbesartan market opportunities vary by end market size?
How does Irbesartan break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Irbesartan Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Irbesartan by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Irbesartan by Country/Region, 2018, 2022 & 2029
2.2 Irbesartan Segment by Type
2.2.1 Combination Drugs
2.2.2 Prescribed Drugs
2.3 Irbesartan Sales by Type
2.3.1 Global Irbesartan Sales Market Share by Type (2018-2023)
2.3.2 Global Irbesartan Revenue and Market Share by Type (2018-2023)
2.3.3 Global Irbesartan Sale Price by Type (2018-2023)
2.4 Irbesartan Segment by Application
2.4.1 Hyperlipidemia
2.4.2 High Blood Pressure
2.4.3 Heart Failure
2.4.4 Kidney Disease
2.4.5 Fibrous Fibrillation
2.4.6 Other
2.5 Irbesartan Sales by Application
2.5.1 Global Irbesartan Sale Market Share by Application (2018-2023)
2.5.2 Global Irbesartan Revenue and Market Share by Application (2018-2023)
2.5.3 Global Irbesartan Sale Price by Application (2018-2023)
3 GLOBAL IRBESARTAN BY COMPANY
3.1 Global Irbesartan Breakdown Data by Company
3.1.1 Global Irbesartan Annual Sales by Company (2018-2023)
3.1.2 Global Irbesartan Sales Market Share by Company (2018-2023)
3.2 Global Irbesartan Annual Revenue by Company (2018-2023)
3.2.1 Global Irbesartan Revenue by Company (2018-2023)
3.2.2 Global Irbesartan Revenue Market Share by Company (2018-2023)
3.3 Global Irbesartan Sale Price by Company
3.4 Key Manufacturers Irbesartan Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Irbesartan Product Location Distribution
3.4.2 Players Irbesartan Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR IRBESARTAN BY GEOGRAPHIC REGION
4.1 World Historic Irbesartan Market Size by Geographic Region (2018-2023)
4.1.1 Global Irbesartan Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Irbesartan Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Irbesartan Market Size by Country/Region (2018-2023)
4.2.1 Global Irbesartan Annual Sales by Country/Region (2018-2023)
4.2.2 Global Irbesartan Annual Revenue by Country/Region (2018-2023)
4.3 Americas Irbesartan Sales Growth
4.4 APAC Irbesartan Sales Growth
4.5 Europe Irbesartan Sales Growth
4.6 Middle East & Africa Irbesartan Sales Growth
5 AMERICAS
5.1 Americas Irbesartan Sales by Country
5.1.1 Americas Irbesartan Sales by Country (2018-2023)
5.1.2 Americas Irbesartan Revenue by Country (2018-2023)
5.2 Americas Irbesartan Sales by Type
5.3 Americas Irbesartan Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Irbesartan Sales by Region
6.1.1 APAC Irbesartan Sales by Region (2018-2023)
6.1.2 APAC Irbesartan Revenue by Region (2018-2023)
6.2 APAC Irbesartan Sales by Type
6.3 APAC Irbesartan Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Irbesartan by Country
7.1.1 Europe Irbesartan Sales by Country (2018-2023)
7.1.2 Europe Irbesartan Revenue by Country (2018-2023)
7.2 Europe Irbesartan Sales by Type
7.3 Europe Irbesartan Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Irbesartan by Country
8.1.1 Middle East & Africa Irbesartan Sales by Country (2018-2023)
8.1.2 Middle East & Africa Irbesartan Revenue by Country (2018-2023)
8.2 Middle East & Africa Irbesartan Sales by Type
8.3 Middle East & Africa Irbesartan Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Irbesartan
10.3 Manufacturing Process Analysis of Irbesartan
10.4 Industry Chain Structure of Irbesartan
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Irbesartan Distributors
11.3 Irbesartan Customer
12 WORLD FORECAST REVIEW FOR IRBESARTAN BY GEOGRAPHIC REGION
12.1 Global Irbesartan Market Size Forecast by Region
12.1.1 Global Irbesartan Forecast by Region (2024-2029)
12.1.2 Global Irbesartan Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Irbesartan Forecast by Type
12.7 Global Irbesartan Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Teva
13.1.1 Teva Company Information
13.1.2 Teva Irbesartan Product Portfolios and Specifications
13.1.3 Teva Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Teva Main Business Overview
13.1.5 Teva Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Irbesartan Product Portfolios and Specifications
13.2.3 Sanofi Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 BMS
13.3.1 BMS Company Information
13.3.2 BMS Irbesartan Product Portfolios and Specifications
13.3.3 BMS Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 BMS Main Business Overview
13.3.5 BMS Latest Developments
13.4 Sumitomo Dainippon Pharma
13.4.1 Sumitomo Dainippon Pharma Company Information
13.4.2 Sumitomo Dainippon Pharma Irbesartan Product Portfolios and Specifications
13.4.3 Sumitomo Dainippon Pharma Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sumitomo Dainippon Pharma Main Business Overview
13.4.5 Sumitomo Dainippon Pharma Latest Developments
13.5 Novartis
13.5.1 Novartis Company Information
13.5.2 Novartis Irbesartan Product Portfolios and Specifications
13.5.3 Novartis Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Novartis Main Business Overview
13.5.5 Novartis Latest Developments
13.6 Shionogi
13.6.1 Shionogi Company Information
13.6.2 Shionogi Irbesartan Product Portfolios and Specifications
13.6.3 Shionogi Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Shionogi Main Business Overview
13.6.5 Shionogi Latest Developments
13.7 Hanall
13.7.1 Hanall Company Information
13.7.2 Hanall Irbesartan Product Portfolios and Specifications
13.7.3 Hanall Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Hanall Main Business Overview
13.7.5 Hanall Latest Developments
13.8 Taj Pharmaceuticals
13.8.1 Taj Pharmaceuticals Company Information
13.8.2 Taj Pharmaceuticals Irbesartan Product Portfolios and Specifications
13.8.3 Taj Pharmaceuticals Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Taj Pharmaceuticals Main Business Overview
13.8.5 Taj Pharmaceuticals Latest Developments
13.9 Apotex
13.9.1 Apotex Company Information
13.9.2 Apotex Irbesartan Product Portfolios and Specifications
13.9.3 Apotex Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Apotex Main Business Overview
13.9.5 Apotex Latest Developments
13.10 Jiangsu Hengrui Medicine
13.10.1 Jiangsu Hengrui Medicine Company Information
13.10.2 Jiangsu Hengrui Medicine Irbesartan Product Portfolios and Specifications
13.10.3 Jiangsu Hengrui Medicine Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Jiangsu Hengrui Medicine Main Business Overview
13.10.5 Jiangsu Hengrui Medicine Latest Developments
13.11 Verdant Life Sciences
13.11.1 Verdant Life Sciences Company Information
13.11.2 Verdant Life Sciences Irbesartan Product Portfolios and Specifications
13.11.3 Verdant Life Sciences Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Verdant Life Sciences Main Business Overview
13.11.5 Verdant Life Sciences Latest Developments
13.12 Angita Pharma
13.12.1 Angita Pharma Company Information
13.12.2 Angita Pharma Irbesartan Product Portfolios and Specifications
13.12.3 Angita Pharma Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Angita Pharma Main Business Overview
13.12.5 Angita Pharma Latest Developments
13.13 Auro Pharma
13.13.1 Auro Pharma Company Information
13.13.2 Auro Pharma Irbesartan Product Portfolios and Specifications
13.13.3 Auro Pharma Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Auro Pharma Main Business Overview
13.13.5 Auro Pharma Latest Developments
13.14 Avanstra
13.14.1 Avanstra Company Information
13.14.2 Avanstra Irbesartan Product Portfolios and Specifications
13.14.3 Avanstra Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Avanstra Main Business Overview
13.14.5 Avanstra Latest Developments
13.15 Zhuhai Rundu Pharma
13.15.1 Zhuhai Rundu Pharma Company Information
13.15.2 Zhuhai Rundu Pharma Irbesartan Product Portfolios and Specifications
13.15.3 Zhuhai Rundu Pharma Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Zhuhai Rundu Pharma Main Business Overview
13.15.5 Zhuhai Rundu Pharma Latest Developments
13.16 Xiansheng Pharmaceutical
13.16.1 Xiansheng Pharmaceutical Company Information
13.16.2 Xiansheng Pharmaceutical Irbesartan Product Portfolios and Specifications
13.16.3 Xiansheng Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Xiansheng Pharmaceutical Main Business Overview
13.16.5 Xiansheng Pharmaceutical Latest Developments
13.17 CTTQ
13.17.1 CTTQ Company Information
13.17.2 CTTQ Irbesartan Product Portfolios and Specifications
13.17.3 CTTQ Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 CTTQ Main Business Overview
13.17.5 CTTQ Latest Developments
13.18 Tianjin Huairen Pharmaceutical
13.18.1 Tianjin Huairen Pharmaceutical Company Information
13.18.2 Tianjin Huairen Pharmaceutical Irbesartan Product Portfolios and Specifications
13.18.3 Tianjin Huairen Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Tianjin Huairen Pharmaceutical Main Business Overview
13.18.5 Tianjin Huairen Pharmaceutical Latest Developments
13.19 Jiangsu Wangao Pharmaceutical
13.19.1 Jiangsu Wangao Pharmaceutical Company Information
13.19.2 Jiangsu Wangao Pharmaceutical Irbesartan Product Portfolios and Specifications
13.19.3 Jiangsu Wangao Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Jiangsu Wangao Pharmaceutical Main Business Overview
13.19.5 Jiangsu Wangao Pharmaceutical Latest Developments
13.20 Zhejiang Huahai Pharmaceutical
13.20.1 Zhejiang Huahai Pharmaceutical Company Information
13.20.2 Zhejiang Huahai Pharmaceutical Irbesartan Product Portfolios and Specifications
13.20.3 Zhejiang Huahai Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Zhejiang Huahai Pharmaceutical Main Business Overview
13.20.5 Zhejiang Huahai Pharmaceutical Latest Developments
13.21 Zhejiang Ainuo Pharmaceutical
13.21.1 Zhejiang Ainuo Pharmaceutical Company Information
13.21.2 Zhejiang Ainuo Pharmaceutical Irbesartan Product Portfolios and Specifications
13.21.3 Zhejiang Ainuo Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 Zhejiang Ainuo Pharmaceutical Main Business Overview
13.21.5 Zhejiang Ainuo Pharmaceutical Latest Developments
13.22 Yuanhe Pharmaceutical
13.22.1 Yuanhe Pharmaceutical Company Information
13.22.2 Yuanhe Pharmaceutical Irbesartan Product Portfolios and Specifications
13.22.3 Yuanhe Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.22.4 Yuanhe Pharmaceutical Main Business Overview
13.22.5 Yuanhe Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Irbesartan Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Irbesartan by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Irbesartan by Country/Region, 2018, 2022 & 2029
2.2 Irbesartan Segment by Type
2.2.1 Combination Drugs
2.2.2 Prescribed Drugs
2.3 Irbesartan Sales by Type
2.3.1 Global Irbesartan Sales Market Share by Type (2018-2023)
2.3.2 Global Irbesartan Revenue and Market Share by Type (2018-2023)
2.3.3 Global Irbesartan Sale Price by Type (2018-2023)
2.4 Irbesartan Segment by Application
2.4.1 Hyperlipidemia
2.4.2 High Blood Pressure
2.4.3 Heart Failure
2.4.4 Kidney Disease
2.4.5 Fibrous Fibrillation
2.4.6 Other
2.5 Irbesartan Sales by Application
2.5.1 Global Irbesartan Sale Market Share by Application (2018-2023)
2.5.2 Global Irbesartan Revenue and Market Share by Application (2018-2023)
2.5.3 Global Irbesartan Sale Price by Application (2018-2023)
3 GLOBAL IRBESARTAN BY COMPANY
3.1 Global Irbesartan Breakdown Data by Company
3.1.1 Global Irbesartan Annual Sales by Company (2018-2023)
3.1.2 Global Irbesartan Sales Market Share by Company (2018-2023)
3.2 Global Irbesartan Annual Revenue by Company (2018-2023)
3.2.1 Global Irbesartan Revenue by Company (2018-2023)
3.2.2 Global Irbesartan Revenue Market Share by Company (2018-2023)
3.3 Global Irbesartan Sale Price by Company
3.4 Key Manufacturers Irbesartan Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Irbesartan Product Location Distribution
3.4.2 Players Irbesartan Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR IRBESARTAN BY GEOGRAPHIC REGION
4.1 World Historic Irbesartan Market Size by Geographic Region (2018-2023)
4.1.1 Global Irbesartan Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Irbesartan Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Irbesartan Market Size by Country/Region (2018-2023)
4.2.1 Global Irbesartan Annual Sales by Country/Region (2018-2023)
4.2.2 Global Irbesartan Annual Revenue by Country/Region (2018-2023)
4.3 Americas Irbesartan Sales Growth
4.4 APAC Irbesartan Sales Growth
4.5 Europe Irbesartan Sales Growth
4.6 Middle East & Africa Irbesartan Sales Growth
5 AMERICAS
5.1 Americas Irbesartan Sales by Country
5.1.1 Americas Irbesartan Sales by Country (2018-2023)
5.1.2 Americas Irbesartan Revenue by Country (2018-2023)
5.2 Americas Irbesartan Sales by Type
5.3 Americas Irbesartan Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Irbesartan Sales by Region
6.1.1 APAC Irbesartan Sales by Region (2018-2023)
6.1.2 APAC Irbesartan Revenue by Region (2018-2023)
6.2 APAC Irbesartan Sales by Type
6.3 APAC Irbesartan Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Irbesartan by Country
7.1.1 Europe Irbesartan Sales by Country (2018-2023)
7.1.2 Europe Irbesartan Revenue by Country (2018-2023)
7.2 Europe Irbesartan Sales by Type
7.3 Europe Irbesartan Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Irbesartan by Country
8.1.1 Middle East & Africa Irbesartan Sales by Country (2018-2023)
8.1.2 Middle East & Africa Irbesartan Revenue by Country (2018-2023)
8.2 Middle East & Africa Irbesartan Sales by Type
8.3 Middle East & Africa Irbesartan Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Irbesartan
10.3 Manufacturing Process Analysis of Irbesartan
10.4 Industry Chain Structure of Irbesartan
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Irbesartan Distributors
11.3 Irbesartan Customer
12 WORLD FORECAST REVIEW FOR IRBESARTAN BY GEOGRAPHIC REGION
12.1 Global Irbesartan Market Size Forecast by Region
12.1.1 Global Irbesartan Forecast by Region (2024-2029)
12.1.2 Global Irbesartan Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Irbesartan Forecast by Type
12.7 Global Irbesartan Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Teva
13.1.1 Teva Company Information
13.1.2 Teva Irbesartan Product Portfolios and Specifications
13.1.3 Teva Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Teva Main Business Overview
13.1.5 Teva Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Irbesartan Product Portfolios and Specifications
13.2.3 Sanofi Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 BMS
13.3.1 BMS Company Information
13.3.2 BMS Irbesartan Product Portfolios and Specifications
13.3.3 BMS Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 BMS Main Business Overview
13.3.5 BMS Latest Developments
13.4 Sumitomo Dainippon Pharma
13.4.1 Sumitomo Dainippon Pharma Company Information
13.4.2 Sumitomo Dainippon Pharma Irbesartan Product Portfolios and Specifications
13.4.3 Sumitomo Dainippon Pharma Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sumitomo Dainippon Pharma Main Business Overview
13.4.5 Sumitomo Dainippon Pharma Latest Developments
13.5 Novartis
13.5.1 Novartis Company Information
13.5.2 Novartis Irbesartan Product Portfolios and Specifications
13.5.3 Novartis Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Novartis Main Business Overview
13.5.5 Novartis Latest Developments
13.6 Shionogi
13.6.1 Shionogi Company Information
13.6.2 Shionogi Irbesartan Product Portfolios and Specifications
13.6.3 Shionogi Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Shionogi Main Business Overview
13.6.5 Shionogi Latest Developments
13.7 Hanall
13.7.1 Hanall Company Information
13.7.2 Hanall Irbesartan Product Portfolios and Specifications
13.7.3 Hanall Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Hanall Main Business Overview
13.7.5 Hanall Latest Developments
13.8 Taj Pharmaceuticals
13.8.1 Taj Pharmaceuticals Company Information
13.8.2 Taj Pharmaceuticals Irbesartan Product Portfolios and Specifications
13.8.3 Taj Pharmaceuticals Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Taj Pharmaceuticals Main Business Overview
13.8.5 Taj Pharmaceuticals Latest Developments
13.9 Apotex
13.9.1 Apotex Company Information
13.9.2 Apotex Irbesartan Product Portfolios and Specifications
13.9.3 Apotex Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Apotex Main Business Overview
13.9.5 Apotex Latest Developments
13.10 Jiangsu Hengrui Medicine
13.10.1 Jiangsu Hengrui Medicine Company Information
13.10.2 Jiangsu Hengrui Medicine Irbesartan Product Portfolios and Specifications
13.10.3 Jiangsu Hengrui Medicine Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Jiangsu Hengrui Medicine Main Business Overview
13.10.5 Jiangsu Hengrui Medicine Latest Developments
13.11 Verdant Life Sciences
13.11.1 Verdant Life Sciences Company Information
13.11.2 Verdant Life Sciences Irbesartan Product Portfolios and Specifications
13.11.3 Verdant Life Sciences Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Verdant Life Sciences Main Business Overview
13.11.5 Verdant Life Sciences Latest Developments
13.12 Angita Pharma
13.12.1 Angita Pharma Company Information
13.12.2 Angita Pharma Irbesartan Product Portfolios and Specifications
13.12.3 Angita Pharma Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Angita Pharma Main Business Overview
13.12.5 Angita Pharma Latest Developments
13.13 Auro Pharma
13.13.1 Auro Pharma Company Information
13.13.2 Auro Pharma Irbesartan Product Portfolios and Specifications
13.13.3 Auro Pharma Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Auro Pharma Main Business Overview
13.13.5 Auro Pharma Latest Developments
13.14 Avanstra
13.14.1 Avanstra Company Information
13.14.2 Avanstra Irbesartan Product Portfolios and Specifications
13.14.3 Avanstra Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Avanstra Main Business Overview
13.14.5 Avanstra Latest Developments
13.15 Zhuhai Rundu Pharma
13.15.1 Zhuhai Rundu Pharma Company Information
13.15.2 Zhuhai Rundu Pharma Irbesartan Product Portfolios and Specifications
13.15.3 Zhuhai Rundu Pharma Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Zhuhai Rundu Pharma Main Business Overview
13.15.5 Zhuhai Rundu Pharma Latest Developments
13.16 Xiansheng Pharmaceutical
13.16.1 Xiansheng Pharmaceutical Company Information
13.16.2 Xiansheng Pharmaceutical Irbesartan Product Portfolios and Specifications
13.16.3 Xiansheng Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Xiansheng Pharmaceutical Main Business Overview
13.16.5 Xiansheng Pharmaceutical Latest Developments
13.17 CTTQ
13.17.1 CTTQ Company Information
13.17.2 CTTQ Irbesartan Product Portfolios and Specifications
13.17.3 CTTQ Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 CTTQ Main Business Overview
13.17.5 CTTQ Latest Developments
13.18 Tianjin Huairen Pharmaceutical
13.18.1 Tianjin Huairen Pharmaceutical Company Information
13.18.2 Tianjin Huairen Pharmaceutical Irbesartan Product Portfolios and Specifications
13.18.3 Tianjin Huairen Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Tianjin Huairen Pharmaceutical Main Business Overview
13.18.5 Tianjin Huairen Pharmaceutical Latest Developments
13.19 Jiangsu Wangao Pharmaceutical
13.19.1 Jiangsu Wangao Pharmaceutical Company Information
13.19.2 Jiangsu Wangao Pharmaceutical Irbesartan Product Portfolios and Specifications
13.19.3 Jiangsu Wangao Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Jiangsu Wangao Pharmaceutical Main Business Overview
13.19.5 Jiangsu Wangao Pharmaceutical Latest Developments
13.20 Zhejiang Huahai Pharmaceutical
13.20.1 Zhejiang Huahai Pharmaceutical Company Information
13.20.2 Zhejiang Huahai Pharmaceutical Irbesartan Product Portfolios and Specifications
13.20.3 Zhejiang Huahai Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Zhejiang Huahai Pharmaceutical Main Business Overview
13.20.5 Zhejiang Huahai Pharmaceutical Latest Developments
13.21 Zhejiang Ainuo Pharmaceutical
13.21.1 Zhejiang Ainuo Pharmaceutical Company Information
13.21.2 Zhejiang Ainuo Pharmaceutical Irbesartan Product Portfolios and Specifications
13.21.3 Zhejiang Ainuo Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 Zhejiang Ainuo Pharmaceutical Main Business Overview
13.21.5 Zhejiang Ainuo Pharmaceutical Latest Developments
13.22 Yuanhe Pharmaceutical
13.22.1 Yuanhe Pharmaceutical Company Information
13.22.2 Yuanhe Pharmaceutical Irbesartan Product Portfolios and Specifications
13.22.3 Yuanhe Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.22.4 Yuanhe Pharmaceutical Main Business Overview
13.22.5 Yuanhe Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Irbesartan Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Irbesartan Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Combination Drugs
Table 4. Major Players of Prescribed Drugs
Table 5. Global Irbesartan Sales by Type (2018-2023) & (KG)
Table 6. Global Irbesartan Sales Market Share by Type (2018-2023)
Table 7. Global Irbesartan Revenue by Type (2018-2023) & ($ million)
Table 8. Global Irbesartan Revenue Market Share by Type (2018-2023)
Table 9. Global Irbesartan Sale Price by Type (2018-2023) & (US$/G)
Table 10. Global Irbesartan Sales by Application (2018-2023) & (KG)
Table 11. Global Irbesartan Sales Market Share by Application (2018-2023)
Table 12. Global Irbesartan Revenue by Application (2018-2023)
Table 13. Global Irbesartan Revenue Market Share by Application (2018-2023)
Table 14. Global Irbesartan Sale Price by Application (2018-2023) & (US$/G)
Table 15. Global Irbesartan Sales by Company (2018-2023) & (KG)
Table 16. Global Irbesartan Sales Market Share by Company (2018-2023)
Table 17. Global Irbesartan Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Irbesartan Revenue Market Share by Company (2018-2023)
Table 19. Global Irbesartan Sale Price by Company (2018-2023) & (US$/G)
Table 20. Key Manufacturers Irbesartan Producing Area Distribution and Sales Area
Table 21. Players Irbesartan Products Offered
Table 22. Irbesartan Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Irbesartan Sales by Geographic Region (2018-2023) & (KG)
Table 26. Global Irbesartan Sales Market Share Geographic Region (2018-2023)
Table 27. Global Irbesartan Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Irbesartan Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Irbesartan Sales by Country/Region (2018-2023) & (KG)
Table 30. Global Irbesartan Sales Market Share by Country/Region (2018-2023)
Table 31. Global Irbesartan Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Irbesartan Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Irbesartan Sales by Country (2018-2023) & (KG)
Table 34. Americas Irbesartan Sales Market Share by Country (2018-2023)
Table 35. Americas Irbesartan Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Irbesartan Revenue Market Share by Country (2018-2023)
Table 37. Americas Irbesartan Sales by Type (2018-2023) & (KG)
Table 38. Americas Irbesartan Sales by Application (2018-2023) & (KG)
Table 39. APAC Irbesartan Sales by Region (2018-2023) & (KG)
Table 40. APAC Irbesartan Sales Market Share by Region (2018-2023)
Table 41. APAC Irbesartan Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Irbesartan Revenue Market Share by Region (2018-2023)
Table 43. APAC Irbesartan Sales by Type (2018-2023) & (KG)
Table 44. APAC Irbesartan Sales by Application (2018-2023) & (KG)
Table 45. Europe Irbesartan Sales by Country (2018-2023) & (KG)
Table 46. Europe Irbesartan Sales Market Share by Country (2018-2023)
Table 47. Europe Irbesartan Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Irbesartan Revenue Market Share by Country (2018-2023)
Table 49. Europe Irbesartan Sales by Type (2018-2023) & (KG)
Table 50. Europe Irbesartan Sales by Application (2018-2023) & (KG)
Table 51. Middle East & Africa Irbesartan Sales by Country (2018-2023) & (KG)
Table 52. Middle East & Africa Irbesartan Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Irbesartan Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Irbesartan Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Irbesartan Sales by Type (2018-2023) & (KG)
Table 56. Middle East & Africa Irbesartan Sales by Application (2018-2023) & (KG)
Table 57. Key Market Drivers & Growth Opportunities of Irbesartan
Table 58. Key Market Challenges & Risks of Irbesartan
Table 59. Key Industry Trends of Irbesartan
Table 60. Irbesartan Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Irbesartan Distributors List
Table 63. Irbesartan Customer List
Table 64. Global Irbesartan Sales Forecast by Region (2024-2029) & (KG)
Table 65. Global Irbesartan Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Irbesartan Sales Forecast by Country (2024-2029) & (KG)
Table 67. Americas Irbesartan Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Irbesartan Sales Forecast by Region (2024-2029) & (KG)
Table 69. APAC Irbesartan Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Irbesartan Sales Forecast by Country (2024-2029) & (KG)
Table 71. Europe Irbesartan Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Irbesartan Sales Forecast by Country (2024-2029) & (KG)
Table 73. Middle East & Africa Irbesartan Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Irbesartan Sales Forecast by Type (2024-2029) & (KG)
Table 75. Global Irbesartan Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Irbesartan Sales Forecast by Application (2024-2029) & (KG)
Table 77. Global Irbesartan Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Teva Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 79. Teva Irbesartan Product Portfolios and Specifications
Table 80. Teva Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 81. Teva Main Business
Table 82. Teva Latest Developments
Table 83. Sanofi Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofi Irbesartan Product Portfolios and Specifications
Table 85. Sanofi Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 86. Sanofi Main Business
Table 87. Sanofi Latest Developments
Table 88. BMS Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 89. BMS Irbesartan Product Portfolios and Specifications
Table 90. BMS Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 91. BMS Main Business
Table 92. BMS Latest Developments
Table 93. Sumitomo Dainippon Pharma Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 94. Sumitomo Dainippon Pharma Irbesartan Product Portfolios and Specifications
Table 95. Sumitomo Dainippon Pharma Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 96. Sumitomo Dainippon Pharma Main Business
Table 97. Sumitomo Dainippon Pharma Latest Developments
Table 98. Novartis Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 99. Novartis Irbesartan Product Portfolios and Specifications
Table 100. Novartis Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 101. Novartis Main Business
Table 102. Novartis Latest Developments
Table 103. Shionogi Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 104. Shionogi Irbesartan Product Portfolios and Specifications
Table 105. Shionogi Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 106. Shionogi Main Business
Table 107. Shionogi Latest Developments
Table 108. Hanall Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 109. Hanall Irbesartan Product Portfolios and Specifications
Table 110. Hanall Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 111. Hanall Main Business
Table 112. Hanall Latest Developments
Table 113. Taj Pharmaceuticals Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 114. Taj Pharmaceuticals Irbesartan Product Portfolios and Specifications
Table 115. Taj Pharmaceuticals Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 116. Taj Pharmaceuticals Main Business
Table 117. Taj Pharmaceuticals Latest Developments
Table 118. Apotex Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 119. Apotex Irbesartan Product Portfolios and Specifications
Table 120. Apotex Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 121. Apotex Main Business
Table 122. Apotex Latest Developments
Table 123. Jiangsu Hengrui Medicine Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 124. Jiangsu Hengrui Medicine Irbesartan Product Portfolios and Specifications
Table 125. Jiangsu Hengrui Medicine Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 126. Jiangsu Hengrui Medicine Main Business
Table 127. Jiangsu Hengrui Medicine Latest Developments
Table 128. Verdant Life Sciences Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 129. Verdant Life Sciences Irbesartan Product Portfolios and Specifications
Table 130. Verdant Life Sciences Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 131. Verdant Life Sciences Main Business
Table 132. Verdant Life Sciences Latest Developments
Table 133. Angita Pharma Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 134. Angita Pharma Irbesartan Product Portfolios and Specifications
Table 135. Angita Pharma Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 136. Angita Pharma Main Business
Table 137. Angita Pharma Latest Developments
Table 138. Auro Pharma Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 139. Auro Pharma Irbesartan Product Portfolios and Specifications
Table 140. Auro Pharma Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 141. Auro Pharma Main Business
Table 142. Auro Pharma Latest Developments
Table 143. Avanstra Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 144. Avanstra Irbesartan Product Portfolios and Specifications
Table 145. Avanstra Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 146. Avanstra Main Business
Table 147. Avanstra Latest Developments
Table 148. Zhuhai Rundu Pharma Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 149. Zhuhai Rundu Pharma Irbesartan Product Portfolios and Specifications
Table 150. Zhuhai Rundu Pharma Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 151. Zhuhai Rundu Pharma Main Business
Table 152. Zhuhai Rundu Pharma Latest Developments
Table 153. Xiansheng Pharmaceutical Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 154. Xiansheng Pharmaceutical Irbesartan Product Portfolios and Specifications
Table 155. Xiansheng Pharmaceutical Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 156. Xiansheng Pharmaceutical Main Business
Table 157. Xiansheng Pharmaceutical Latest Developments
Table 158. CTTQ Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 159. CTTQ Irbesartan Product Portfolios and Specifications
Table 160. CTTQ Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 161. CTTQ Main Business
Table 162. CTTQ Latest Developments
Table 163. Tianjin Huairen Pharmaceutical Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 164. Tianjin Huairen Pharmaceutical Irbesartan Product Portfolios and Specifications
Table 165. Tianjin Huairen Pharmaceutical Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 166. Tianjin Huairen Pharmaceutical Main Business
Table 167. Tianjin Huairen Pharmaceutical Latest Developments
Table 168. Jiangsu Wangao Pharmaceutical Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 169. Jiangsu Wangao Pharmaceutical Irbesartan Product Portfolios and Specifications
Table 170. Jiangsu Wangao Pharmaceutical Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 171. Jiangsu Wangao Pharmaceutical Main Business
Table 172. Jiangsu Wangao Pharmaceutical Latest Developments
Table 173. Zhejiang Huahai Pharmaceutical Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 174. Zhejiang Huahai Pharmaceutical Irbesartan Product Portfolios and Specifications
Table 175. Zhejiang Huahai Pharmaceutical Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 176. Zhejiang Huahai Pharmaceutical Main Business
Table 177. Zhejiang Huahai Pharmaceutical Latest Developments
Table 178. Zhejiang Ainuo Pharmaceutical Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 179. Zhejiang Ainuo Pharmaceutical Irbesartan Product Portfolios and Specifications
Table 180. Zhejiang Ainuo Pharmaceutical Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 181. Zhejiang Ainuo Pharmaceutical Main Business
Table 182. Zhejiang Ainuo Pharmaceutical Latest Developments
Table 183. Yuanhe Pharmaceutical Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 184. Yuanhe Pharmaceutical Irbesartan Product Portfolios and Specifications
Table 185. Yuanhe Pharmaceutical Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 186. Yuanhe Pharmaceutical Main Business
Table 187. Yuanhe Pharmaceutical Latest Developments
Table 1. Irbesartan Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Irbesartan Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Combination Drugs
Table 4. Major Players of Prescribed Drugs
Table 5. Global Irbesartan Sales by Type (2018-2023) & (KG)
Table 6. Global Irbesartan Sales Market Share by Type (2018-2023)
Table 7. Global Irbesartan Revenue by Type (2018-2023) & ($ million)
Table 8. Global Irbesartan Revenue Market Share by Type (2018-2023)
Table 9. Global Irbesartan Sale Price by Type (2018-2023) & (US$/G)
Table 10. Global Irbesartan Sales by Application (2018-2023) & (KG)
Table 11. Global Irbesartan Sales Market Share by Application (2018-2023)
Table 12. Global Irbesartan Revenue by Application (2018-2023)
Table 13. Global Irbesartan Revenue Market Share by Application (2018-2023)
Table 14. Global Irbesartan Sale Price by Application (2018-2023) & (US$/G)
Table 15. Global Irbesartan Sales by Company (2018-2023) & (KG)
Table 16. Global Irbesartan Sales Market Share by Company (2018-2023)
Table 17. Global Irbesartan Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Irbesartan Revenue Market Share by Company (2018-2023)
Table 19. Global Irbesartan Sale Price by Company (2018-2023) & (US$/G)
Table 20. Key Manufacturers Irbesartan Producing Area Distribution and Sales Area
Table 21. Players Irbesartan Products Offered
Table 22. Irbesartan Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Irbesartan Sales by Geographic Region (2018-2023) & (KG)
Table 26. Global Irbesartan Sales Market Share Geographic Region (2018-2023)
Table 27. Global Irbesartan Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Irbesartan Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Irbesartan Sales by Country/Region (2018-2023) & (KG)
Table 30. Global Irbesartan Sales Market Share by Country/Region (2018-2023)
Table 31. Global Irbesartan Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Irbesartan Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Irbesartan Sales by Country (2018-2023) & (KG)
Table 34. Americas Irbesartan Sales Market Share by Country (2018-2023)
Table 35. Americas Irbesartan Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Irbesartan Revenue Market Share by Country (2018-2023)
Table 37. Americas Irbesartan Sales by Type (2018-2023) & (KG)
Table 38. Americas Irbesartan Sales by Application (2018-2023) & (KG)
Table 39. APAC Irbesartan Sales by Region (2018-2023) & (KG)
Table 40. APAC Irbesartan Sales Market Share by Region (2018-2023)
Table 41. APAC Irbesartan Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Irbesartan Revenue Market Share by Region (2018-2023)
Table 43. APAC Irbesartan Sales by Type (2018-2023) & (KG)
Table 44. APAC Irbesartan Sales by Application (2018-2023) & (KG)
Table 45. Europe Irbesartan Sales by Country (2018-2023) & (KG)
Table 46. Europe Irbesartan Sales Market Share by Country (2018-2023)
Table 47. Europe Irbesartan Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Irbesartan Revenue Market Share by Country (2018-2023)
Table 49. Europe Irbesartan Sales by Type (2018-2023) & (KG)
Table 50. Europe Irbesartan Sales by Application (2018-2023) & (KG)
Table 51. Middle East & Africa Irbesartan Sales by Country (2018-2023) & (KG)
Table 52. Middle East & Africa Irbesartan Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Irbesartan Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Irbesartan Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Irbesartan Sales by Type (2018-2023) & (KG)
Table 56. Middle East & Africa Irbesartan Sales by Application (2018-2023) & (KG)
Table 57. Key Market Drivers & Growth Opportunities of Irbesartan
Table 58. Key Market Challenges & Risks of Irbesartan
Table 59. Key Industry Trends of Irbesartan
Table 60. Irbesartan Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Irbesartan Distributors List
Table 63. Irbesartan Customer List
Table 64. Global Irbesartan Sales Forecast by Region (2024-2029) & (KG)
Table 65. Global Irbesartan Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Irbesartan Sales Forecast by Country (2024-2029) & (KG)
Table 67. Americas Irbesartan Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Irbesartan Sales Forecast by Region (2024-2029) & (KG)
Table 69. APAC Irbesartan Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Irbesartan Sales Forecast by Country (2024-2029) & (KG)
Table 71. Europe Irbesartan Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Irbesartan Sales Forecast by Country (2024-2029) & (KG)
Table 73. Middle East & Africa Irbesartan Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Irbesartan Sales Forecast by Type (2024-2029) & (KG)
Table 75. Global Irbesartan Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Irbesartan Sales Forecast by Application (2024-2029) & (KG)
Table 77. Global Irbesartan Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Teva Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 79. Teva Irbesartan Product Portfolios and Specifications
Table 80. Teva Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 81. Teva Main Business
Table 82. Teva Latest Developments
Table 83. Sanofi Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofi Irbesartan Product Portfolios and Specifications
Table 85. Sanofi Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 86. Sanofi Main Business
Table 87. Sanofi Latest Developments
Table 88. BMS Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 89. BMS Irbesartan Product Portfolios and Specifications
Table 90. BMS Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 91. BMS Main Business
Table 92. BMS Latest Developments
Table 93. Sumitomo Dainippon Pharma Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 94. Sumitomo Dainippon Pharma Irbesartan Product Portfolios and Specifications
Table 95. Sumitomo Dainippon Pharma Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 96. Sumitomo Dainippon Pharma Main Business
Table 97. Sumitomo Dainippon Pharma Latest Developments
Table 98. Novartis Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 99. Novartis Irbesartan Product Portfolios and Specifications
Table 100. Novartis Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 101. Novartis Main Business
Table 102. Novartis Latest Developments
Table 103. Shionogi Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 104. Shionogi Irbesartan Product Portfolios and Specifications
Table 105. Shionogi Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 106. Shionogi Main Business
Table 107. Shionogi Latest Developments
Table 108. Hanall Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 109. Hanall Irbesartan Product Portfolios and Specifications
Table 110. Hanall Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 111. Hanall Main Business
Table 112. Hanall Latest Developments
Table 113. Taj Pharmaceuticals Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 114. Taj Pharmaceuticals Irbesartan Product Portfolios and Specifications
Table 115. Taj Pharmaceuticals Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 116. Taj Pharmaceuticals Main Business
Table 117. Taj Pharmaceuticals Latest Developments
Table 118. Apotex Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 119. Apotex Irbesartan Product Portfolios and Specifications
Table 120. Apotex Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 121. Apotex Main Business
Table 122. Apotex Latest Developments
Table 123. Jiangsu Hengrui Medicine Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 124. Jiangsu Hengrui Medicine Irbesartan Product Portfolios and Specifications
Table 125. Jiangsu Hengrui Medicine Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 126. Jiangsu Hengrui Medicine Main Business
Table 127. Jiangsu Hengrui Medicine Latest Developments
Table 128. Verdant Life Sciences Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 129. Verdant Life Sciences Irbesartan Product Portfolios and Specifications
Table 130. Verdant Life Sciences Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 131. Verdant Life Sciences Main Business
Table 132. Verdant Life Sciences Latest Developments
Table 133. Angita Pharma Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 134. Angita Pharma Irbesartan Product Portfolios and Specifications
Table 135. Angita Pharma Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 136. Angita Pharma Main Business
Table 137. Angita Pharma Latest Developments
Table 138. Auro Pharma Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 139. Auro Pharma Irbesartan Product Portfolios and Specifications
Table 140. Auro Pharma Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 141. Auro Pharma Main Business
Table 142. Auro Pharma Latest Developments
Table 143. Avanstra Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 144. Avanstra Irbesartan Product Portfolios and Specifications
Table 145. Avanstra Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 146. Avanstra Main Business
Table 147. Avanstra Latest Developments
Table 148. Zhuhai Rundu Pharma Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 149. Zhuhai Rundu Pharma Irbesartan Product Portfolios and Specifications
Table 150. Zhuhai Rundu Pharma Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 151. Zhuhai Rundu Pharma Main Business
Table 152. Zhuhai Rundu Pharma Latest Developments
Table 153. Xiansheng Pharmaceutical Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 154. Xiansheng Pharmaceutical Irbesartan Product Portfolios and Specifications
Table 155. Xiansheng Pharmaceutical Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 156. Xiansheng Pharmaceutical Main Business
Table 157. Xiansheng Pharmaceutical Latest Developments
Table 158. CTTQ Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 159. CTTQ Irbesartan Product Portfolios and Specifications
Table 160. CTTQ Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 161. CTTQ Main Business
Table 162. CTTQ Latest Developments
Table 163. Tianjin Huairen Pharmaceutical Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 164. Tianjin Huairen Pharmaceutical Irbesartan Product Portfolios and Specifications
Table 165. Tianjin Huairen Pharmaceutical Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 166. Tianjin Huairen Pharmaceutical Main Business
Table 167. Tianjin Huairen Pharmaceutical Latest Developments
Table 168. Jiangsu Wangao Pharmaceutical Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 169. Jiangsu Wangao Pharmaceutical Irbesartan Product Portfolios and Specifications
Table 170. Jiangsu Wangao Pharmaceutical Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 171. Jiangsu Wangao Pharmaceutical Main Business
Table 172. Jiangsu Wangao Pharmaceutical Latest Developments
Table 173. Zhejiang Huahai Pharmaceutical Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 174. Zhejiang Huahai Pharmaceutical Irbesartan Product Portfolios and Specifications
Table 175. Zhejiang Huahai Pharmaceutical Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 176. Zhejiang Huahai Pharmaceutical Main Business
Table 177. Zhejiang Huahai Pharmaceutical Latest Developments
Table 178. Zhejiang Ainuo Pharmaceutical Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 179. Zhejiang Ainuo Pharmaceutical Irbesartan Product Portfolios and Specifications
Table 180. Zhejiang Ainuo Pharmaceutical Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 181. Zhejiang Ainuo Pharmaceutical Main Business
Table 182. Zhejiang Ainuo Pharmaceutical Latest Developments
Table 183. Yuanhe Pharmaceutical Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors
Table 184. Yuanhe Pharmaceutical Irbesartan Product Portfolios and Specifications
Table 185. Yuanhe Pharmaceutical Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 186. Yuanhe Pharmaceutical Main Business
Table 187. Yuanhe Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Irbesartan
Figure 2. Irbesartan Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Irbesartan Sales Growth Rate 2018-2029 (KG)
Figure 7. Global Irbesartan Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Irbesartan Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Combination Drugs
Figure 10. Product Picture of Prescribed Drugs
Figure 11. Global Irbesartan Sales Market Share by Type in 2022
Figure 12. Global Irbesartan Revenue Market Share by Type (2018-2023)
Figure 13. Irbesartan Consumed in Hyperlipidemia
Figure 14. Global Irbesartan Market: Hyperlipidemia (2018-2023) & (KG)
Figure 15. Irbesartan Consumed in High Blood Pressure
Figure 16. Global Irbesartan Market: High Blood Pressure (2018-2023) & (KG)
Figure 17. Irbesartan Consumed in Heart Failure
Figure 18. Global Irbesartan Market: Heart Failure (2018-2023) & (KG)
Figure 19. Irbesartan Consumed in Kidney Disease
Figure 20. Global Irbesartan Market: Kidney Disease (2018-2023) & (KG)
Figure 21. Irbesartan Consumed in Fibrous Fibrillation
Figure 22. Global Irbesartan Market: Fibrous Fibrillation (2018-2023) & (KG)
Figure 23. Irbesartan Consumed in Other
Figure 24. Global Irbesartan Market: Other (2018-2023) & (KG)
Figure 25. Global Irbesartan Sales Market Share by Application (2022)
Figure 26. Global Irbesartan Revenue Market Share by Application in 2022
Figure 27. Irbesartan Sales Market by Company in 2022 (KG)
Figure 28. Global Irbesartan Sales Market Share by Company in 2022
Figure 29. Irbesartan Revenue Market by Company in 2022 ($ Million)
Figure 30. Global Irbesartan Revenue Market Share by Company in 2022
Figure 31. Global Irbesartan Sales Market Share by Geographic Region (2018-2023)
Figure 32. Global Irbesartan Revenue Market Share by Geographic Region in 2022
Figure 33. Americas Irbesartan Sales 2018-2023 (KG)
Figure 34. Americas Irbesartan Revenue 2018-2023 ($ Millions)
Figure 35. APAC Irbesartan Sales 2018-2023 (KG)
Figure 36. APAC Irbesartan Revenue 2018-2023 ($ Millions)
Figure 37. Europe Irbesartan Sales 2018-2023 (KG)
Figure 38. Europe Irbesartan Revenue 2018-2023 ($ Millions)
Figure 39. Middle East & Africa Irbesartan Sales 2018-2023 (KG)
Figure 40. Middle East & Africa Irbesartan Revenue 2018-2023 ($ Millions)
Figure 41. Americas Irbesartan Sales Market Share by Country in 2022
Figure 42. Americas Irbesartan Revenue Market Share by Country in 2022
Figure 43. Americas Irbesartan Sales Market Share by Type (2018-2023)
Figure 44. Americas Irbesartan Sales Market Share by Application (2018-2023)
Figure 45. United States Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 46. Canada Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 47. Mexico Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 48. Brazil Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 49. APAC Irbesartan Sales Market Share by Region in 2022
Figure 50. APAC Irbesartan Revenue Market Share by Regions in 2022
Figure 51. APAC Irbesartan Sales Market Share by Type (2018-2023)
Figure 52. APAC Irbesartan Sales Market Share by Application (2018-2023)
Figure 53. China Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 54. Japan Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 55. South Korea Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 56. Southeast Asia Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 57. India Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 58. Australia Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 59. China Taiwan Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 60. Europe Irbesartan Sales Market Share by Country in 2022
Figure 61. Europe Irbesartan Revenue Market Share by Country in 2022
Figure 62. Europe Irbesartan Sales Market Share by Type (2018-2023)
Figure 63. Europe Irbesartan Sales Market Share by Application (2018-2023)
Figure 64. Germany Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 65. France Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 66. UK Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 67. Italy Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 68. Russia Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 69. Middle East & Africa Irbesartan Sales Market Share by Country in 2022
Figure 70. Middle East & Africa Irbesartan Revenue Market Share by Country in 2022
Figure 71. Middle East & Africa Irbesartan Sales Market Share by Type (2018-2023)
Figure 72. Middle East & Africa Irbesartan Sales Market Share by Application (2018-2023)
Figure 73. Egypt Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 74. South Africa Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 75. Israel Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 76. Turkey Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 77. GCC Country Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Irbesartan in 2022
Figure 79. Manufacturing Process Analysis of Irbesartan
Figure 80. Industry Chain Structure of Irbesartan
Figure 81. Channels of Distribution
Figure 82. Global Irbesartan Sales Market Forecast by Region (2024-2029)
Figure 83. Global Irbesartan Revenue Market Share Forecast by Region (2024-2029)
Figure 84. Global Irbesartan Sales Market Share Forecast by Type (2024-2029)
Figure 85. Global Irbesartan Revenue Market Share Forecast by Type (2024-2029)
Figure 86. Global Irbesartan Sales Market Share Forecast by Application (2024-2029)
Figure 87. Global Irbesartan Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Irbesartan
Figure 2. Irbesartan Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Irbesartan Sales Growth Rate 2018-2029 (KG)
Figure 7. Global Irbesartan Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Irbesartan Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Combination Drugs
Figure 10. Product Picture of Prescribed Drugs
Figure 11. Global Irbesartan Sales Market Share by Type in 2022
Figure 12. Global Irbesartan Revenue Market Share by Type (2018-2023)
Figure 13. Irbesartan Consumed in Hyperlipidemia
Figure 14. Global Irbesartan Market: Hyperlipidemia (2018-2023) & (KG)
Figure 15. Irbesartan Consumed in High Blood Pressure
Figure 16. Global Irbesartan Market: High Blood Pressure (2018-2023) & (KG)
Figure 17. Irbesartan Consumed in Heart Failure
Figure 18. Global Irbesartan Market: Heart Failure (2018-2023) & (KG)
Figure 19. Irbesartan Consumed in Kidney Disease
Figure 20. Global Irbesartan Market: Kidney Disease (2018-2023) & (KG)
Figure 21. Irbesartan Consumed in Fibrous Fibrillation
Figure 22. Global Irbesartan Market: Fibrous Fibrillation (2018-2023) & (KG)
Figure 23. Irbesartan Consumed in Other
Figure 24. Global Irbesartan Market: Other (2018-2023) & (KG)
Figure 25. Global Irbesartan Sales Market Share by Application (2022)
Figure 26. Global Irbesartan Revenue Market Share by Application in 2022
Figure 27. Irbesartan Sales Market by Company in 2022 (KG)
Figure 28. Global Irbesartan Sales Market Share by Company in 2022
Figure 29. Irbesartan Revenue Market by Company in 2022 ($ Million)
Figure 30. Global Irbesartan Revenue Market Share by Company in 2022
Figure 31. Global Irbesartan Sales Market Share by Geographic Region (2018-2023)
Figure 32. Global Irbesartan Revenue Market Share by Geographic Region in 2022
Figure 33. Americas Irbesartan Sales 2018-2023 (KG)
Figure 34. Americas Irbesartan Revenue 2018-2023 ($ Millions)
Figure 35. APAC Irbesartan Sales 2018-2023 (KG)
Figure 36. APAC Irbesartan Revenue 2018-2023 ($ Millions)
Figure 37. Europe Irbesartan Sales 2018-2023 (KG)
Figure 38. Europe Irbesartan Revenue 2018-2023 ($ Millions)
Figure 39. Middle East & Africa Irbesartan Sales 2018-2023 (KG)
Figure 40. Middle East & Africa Irbesartan Revenue 2018-2023 ($ Millions)
Figure 41. Americas Irbesartan Sales Market Share by Country in 2022
Figure 42. Americas Irbesartan Revenue Market Share by Country in 2022
Figure 43. Americas Irbesartan Sales Market Share by Type (2018-2023)
Figure 44. Americas Irbesartan Sales Market Share by Application (2018-2023)
Figure 45. United States Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 46. Canada Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 47. Mexico Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 48. Brazil Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 49. APAC Irbesartan Sales Market Share by Region in 2022
Figure 50. APAC Irbesartan Revenue Market Share by Regions in 2022
Figure 51. APAC Irbesartan Sales Market Share by Type (2018-2023)
Figure 52. APAC Irbesartan Sales Market Share by Application (2018-2023)
Figure 53. China Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 54. Japan Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 55. South Korea Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 56. Southeast Asia Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 57. India Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 58. Australia Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 59. China Taiwan Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 60. Europe Irbesartan Sales Market Share by Country in 2022
Figure 61. Europe Irbesartan Revenue Market Share by Country in 2022
Figure 62. Europe Irbesartan Sales Market Share by Type (2018-2023)
Figure 63. Europe Irbesartan Sales Market Share by Application (2018-2023)
Figure 64. Germany Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 65. France Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 66. UK Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 67. Italy Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 68. Russia Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 69. Middle East & Africa Irbesartan Sales Market Share by Country in 2022
Figure 70. Middle East & Africa Irbesartan Revenue Market Share by Country in 2022
Figure 71. Middle East & Africa Irbesartan Sales Market Share by Type (2018-2023)
Figure 72. Middle East & Africa Irbesartan Sales Market Share by Application (2018-2023)
Figure 73. Egypt Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 74. South Africa Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 75. Israel Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 76. Turkey Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 77. GCC Country Irbesartan Revenue Growth 2018-2023 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Irbesartan in 2022
Figure 79. Manufacturing Process Analysis of Irbesartan
Figure 80. Industry Chain Structure of Irbesartan
Figure 81. Channels of Distribution
Figure 82. Global Irbesartan Sales Market Forecast by Region (2024-2029)
Figure 83. Global Irbesartan Revenue Market Share Forecast by Region (2024-2029)
Figure 84. Global Irbesartan Sales Market Share Forecast by Type (2024-2029)
Figure 85. Global Irbesartan Revenue Market Share Forecast by Type (2024-2029)
Figure 86. Global Irbesartan Sales Market Share Forecast by Application (2024-2029)
Figure 87. Global Irbesartan Revenue Market Share Forecast by Application (2024-2029)
